Risk factors for genital infections in people initiating SGLT2 inhibitors and their impact on discontinuation

INTRODUCTION: To identify risk factors, absolute risk, and impact on treatment discontinuation of genital infections with sodium-glucose co-transporter-2 inhibitors (SGLT2i). RESEARCH DESIGN AND METHODS: We assessed the relationship between baseline characteristics and genital infection in 21 004 pe...

Descripción completa

Detalles Bibliográficos
Autores principales: McGovern, Andrew P, Hogg, Michael, Shields, Beverley M, Sattar, Naveed A, Holman, Rury R, Pearson, Ewan R, Hattersley, Andrew T, Jones, Angus G, Dennis, John M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Emerging Technologies, Pharmacology and Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252998/
https://www.ncbi.nlm.nih.gov/pubmed/32448787
http://dx.doi.org/10.1136/bmjdrc-2020-001238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252998/
https://www.ncbi.nlm.nih.gov/pubmed/32448787
http://dx.doi.org/10.1136/bmjdrc-2020-001238

Ejemplares similares